Stock Report

Download full stock data and analysis for free Last Updated: 10-Oct-2026

Stock Rating

Is this stock worth it? Our ratings reveal the truth.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Globus Medical (GMED) Peer Comparison

Stock Card factsheet share-fund-plan-icon

$74.97

up-down-arrow $1.64 (2.23%)

As on 09-Oct-2026 13:42EDT

Market cap

info icon

$9,845 Mln

Revenue (TTM)

info icon

$3,145 Mln

P/E Ratio

info icon

18.8

P/B Ratio

info icon

2.1

Div. Yield

info icon

0 %

Edit peer-selector-edit
Globus Medical (GMED) Koninklijke Philips N.V. NY Registry Shares - ADR Align Technology (ALGN) Bio-Rad Laboratories Inc. Class A (BIO) Henry Schein (HSIC)
Market cap ($ Mln)
 9,845 23,751 10,211 9,799 9,460
Revenue ($ Mln)
 3,145 17,664 4,140 2,589 13,602
Net Profit ($ Mln)
 535.46 1,114.00 413.58 222.40 403.00
Net Margin (%)
 17.03 6.31 9.99 8.59 2.96
RoE (%)
 11.46 9.93 9.99 3.04 11.87
Price to Earnings
 18.80 18.13 25.26 46.41 24.75
Price-To-Book
 2.08 1.86 2.49 1.41 3.09

Income Statement ($ Mln)

Globus Medical (GMED) Koninklijke Philips N.V. NY Registry Shares - ADR Align Technology (ALGN) Bio-Rad Laboratories Inc. Class A (BIO) Henry Schein (HSIC)
Operating Revenue arrow
3,144.90 17,664.00 4,139.53 2,589.30 13,602.00
Cost of Revenue arrow
989.14 9,551.00 1,387.59 1,245.50 9,479.00
Gross Profit arrow
1,981.10 8,058.00 2,756.90 1,343.60 3,842.00
Operating Expenses arrow
1,504.66 6,392.00 2,200.16 1,108.90 3,349.00
Operating Profit (EBIT) arrow
652.69 1,721.00 551.86 235.00 774.00
Other Income arrow
0.00 0.00 0.00 0.00 0.00
Profit before Tax arrow
664.95 1,477.00 568.91 350.40 558.00
Provision for Tax arrow
129.49 364.00 155.33 128.00 132.00
Profit after Tax (Net Income) arrow
535.46 1,114.00 413.58 222.40 403.00
Minority Interest arrow
0.00 -2.00 0.00 0.00 -23.00
Consolidated Profit arrow
0.00 579.00 0.00 378.10 0.00

Liabilities ($ Mln)

Globus Medical (GMED) Koninklijke Philips N.V. NY Registry Shares - ADR Align Technology (ALGN) Bio-Rad Laboratories Inc. Class A (BIO) Henry Schein (HSIC)
Shareholder's Funds arrow
4,768.60 11,447.00 4,232.45 7,173.90 3,157.00
Minority Interest arrow
0.00 -2.00 0.00 0.00 -23.00
Non-Current Liabilities arrow
240.31 7,802.00 276.53 2,116.80 3,170.00
Current Liabilities arrow
479.35 7,423.00 1,908.60 961.30 3,488.00
Total Liabilities arrow
5,302.76 26,944.00 6,233.69 10,576.50 11,215.00

Assets ($ Mln)

Globus Medical (GMED) Koninklijke Philips N.V. NY Registry Shares - ADR Align Technology (ALGN) Bio-Rad Laboratories Inc. Class A (BIO) Henry Schein (HSIC)
Non-Current Assets arrow
3,272.75 17,371.00 3,754.53 7,231.50 6,781.00
Current Assets arrow
2,215.51 9,330.00 2,663.05 3,020.50 4,600.00
Total Assets arrow
5,302.76 26,944.00 6,233.69 10,576.50 11,215.00
Total Debt* arrow
111.19 7,465.00 120.84 1,203.70 3,813.00
Net Current Assets arrow
1,736.17 1,907.00 754.45 2,059.20 1,112.00

Cashflow ($ Mln)

Globus Medical (GMED) Koninklijke Philips N.V. NY Registry Shares - ADR Align Technology (ALGN) Bio-Rad Laboratories Inc. Class A (BIO) Henry Schein (HSIC)
Cash From Operating Activities arrow
753.45 1,162.00 593.22 532.20 712.00
Cash Flow from Investing Activities arrow
-355.01 -737.00 -112.45 -189.70 -477.00
Cash from Financing Activities arrow
-679.16 107.00 -464.58 -283.20 -111.00
Net Cash Inflow / Outflow arrow
-- -- -- -- --

Ratios

Profitability Ratios

 Globus Medical (GMED) Koninklijke Philips N.V. NY Registry Shares - ADR Align Technology (ALGN) Bio-Rad Laboratories Inc. Class A (BIO) Henry Schein (HSIC)
ROCE (%) arrow
11.44 4.64 10.09 8.98 6.03
ROE (%) arrow
11.46 9.93 9.99 3.04 11.87
ROA (%) arrow
9.43 3.29 5.00 2.02 2.80
EBIT Margin (%) arrow
21.14 10.30 15.19 15.42 5.28
Net Margin (%) arrow
17.03 6.31 9.99 8.59 2.96
Cash Profit Margin (%) arrow
0.00 0.00 0.00 0.00 0.00

Growth Ratios

 Globus Medical (GMED) Koninklijke Philips N.V. NY Registry Shares - ADR Align Technology (ALGN) Bio-Rad Laboratories Inc. Class A (BIO) Henry Schein (HSIC)
Revenue Growth (%) arrow
19.74 -1.08 4.41 1.37 6.49
EBIT Growth (%) arrow
91.67 59.79 -3.03 -20.02 8.46
Net Profit Growth (%) arrow
50.14 587.65 -5.49 -30.32 3.60
EPS Growth (%) arrow
50.51 579.15 -2.80 -29.66 10.35
Book Value Growth (%) arrow
9.65 8.94 9.63 2.19 -1.75

Valuation Ratios

 Globus Medical (GMED) Koninklijke Philips N.V. NY Registry Shares - ADR Align Technology (ALGN) Bio-Rad Laboratories Inc. Class A (BIO) Henry Schein (HSIC)
Price / Earnings arrow
22.27 29.23 27.31 10.77 22.47
Price / Book Value arrow
2.08 1.86 2.77 1.41 2.76
Dividend Yield (%) arrow
0.00 4.17 -- 0.00 --
EV/EBITDA arrow
9.95 9.53 13.35 19.02 12.40
Market Cap ($ Cr) arrow
-- -- -- -- --

Solvency Ratios

 Globus Medical (GMED) Koninklijke Philips N.V. NY Registry Shares - ADR Align Technology (ALGN) Bio-Rad Laboratories Inc. Class A (BIO) Henry Schein (HSIC)
Debt to Equity arrow
0.00 0.55 0.00 0.11 0.73
Short term debt to equity ratio arrow
0.00 0.10 0.01 0.06 0.39
Current Ratio arrow
4.62 1.26 1.40 3.14 1.32
Quick Ratio arrow
2.93 0.82 1.28 2.33 0.73
Interest Coverage arrow
97.52 5.06 364.75 8.18 4.51

Operating Efficiency Ratios

 Globus Medical (GMED) Koninklijke Philips N.V. NY Registry Shares - ADR Align Technology (ALGN) Bio-Rad Laboratories Inc. Class A (BIO) Henry Schein (HSIC)
Debtors to sales (%) arrow
23.51 20.36 27.74 17.06 12.96
Asset Turnover arrow
0.55 0.52 0.50 0.24 0.95
Receivable days arrow
82.15 73.75 99.00 65.39 43.40
Inventory Days arrow
270.47 113.36 68.68 221.09 74.52
Payable days arrow
33.17 70.18 32.89 37.02 41.37
Cash Conversion Cycle arrow
319.45 116.92 134.79 249.46 76.55
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...